Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre

Olena Oliveira (Porto, Portugal), Olena Oliveira, Anabela Silva, Ana Antunes, Ricardo Reis, Ana Horta, Raquel Duarte

Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Session: Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Session type: Thematic Poster Session
Number: 2700
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Olena Oliveira (Porto, Portugal), Olena Oliveira, Anabela Silva, Ana Antunes, Ricardo Reis, Ana Horta, Raquel Duarte. Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre. Eur Respir J 2015; 46: Suppl. 59, 2700

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of tuberculosis (TB) at a district general hospital: An audit of practice
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Experience of managing TB/HIV infection in a regional UK center over a 5 year period
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016


Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Out-patient MDR-TB care in Moldova
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

The health economics of treating MDR-TB in the Indian private sector
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Latent TB in healthcare workers from high prevalence countries at city hospital Sunderland foundation trust (CHSFT); epidemiology and management
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


HIV-TB national program integration- 4 year experience at tertiary care hospital
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Number of tuberculosis (TB) cases reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Patient and health system delays for tuberculosis patients diagnosed in medical colleges of Puducherry in India
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016